Nevertheless, altered expression of GAS5 has been reported in diseases other than cancer, including neurogenerative disorders (i.e., Alzheimer’s [69]), autoimmune diseases (i.e., rheumatoid arthritis [70]), knee osteoarthritis [71], and preeclampsia [72]. This evidence concerns the gene GAS5 and preeclampsia.